The effectiveness of psychological interventions alone, or in combination with phosphodiesterase-5 inhibitors, for the treatment of erectile dysfunction:A systematic review

被引:7
|
作者
Atallah, Sandrine [1 ]
Haydar, Asad [2 ]
Jabbour, Teddy [2 ]
Kfoury, Peter [3 ]
Sader, Georgio [2 ]
机构
[1] Amer Univ Beirut Med Ctr AUBMC, Dept Obstet & Gynecol, Beirut, Lebanon
[2] Univ Balamand, Fac Med, Koura, Lebanon
[3] Amer Univ Beirut, Fac Med, Beirut, Lebanon
关键词
Erectile dysfunction; systematic review; psychological intervention; combined therapy; phosphodiesterase; 5; inhibitors; cognitive behavioural therapy; 4TH INTERNATIONAL CONSULTATION; COGNITIVE-BEHAVIORAL THERAPY; SEX THERAPY; CONSENSUS STATEMENT; ADJUNCT TREATMENT; YOUNG MEN; HEALTH; SILDENAFIL; MEDICINE; PSYCHOTHERAPY;
D O I
10.1080/2090598X.2021.1926763
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To highlight the efficacy of various psychological interventions (PI) when used in combination with, or in place of, phosphodiesterase-5 inhibitors (PDE-5i), as compared to the traditional treatment of men with erectile dysfunction (ED) with PDE-5i alone. Methods: A comprehensive literature review for the years 2005-2020 via MEDLINE and PubMed. We included randomised controlled trials that compared the use of either PDE-5i alone, PI alone or a combination of PDE-5i and PI in the treatment of psychogenic ED. All studies included were performed in adults aged 19-55 years and were written in English. Results: A total of 13 articles, with an overall sample of 597 men, were included in this systematic review. The results show that the combination of PI and PDE-5i was more effective than either PI or PDE-5i alone, on erectile function and long-term sexual satisfaction in men with psychogenic ED. Combined interventions were found to be significantly superior to medical treatment in seven studies and to PI alone in one study. In comparing PI to PDE-5i, two studies found PI to be significantly superior to PDE-51 use. In three other studies, PI was found significantly superior to no treatment at all, although some participants in the control group had taken PDE-5i. Conclusions: The combination of PDE-5i with PI shows real promise for the treatment of psychogenic ED. However, no conclusions could be made about what PI is more promising than the other and larger studies are needed to confirm these initial findings.
引用
收藏
页码:310 / 322
页数:13
相关论文
共 50 条
  • [1] Combination of Psychological Intervention and Phosphodiesterase-5 Inhibitors for Erectile Dysfunction: A Narrative Review and Meta-Analysis
    Schmidt, Hannah M.
    Munder, Thomas
    Gerger, Heike
    Fruehauf, Sarah
    Barth, Juergen
    [J]. JOURNAL OF SEXUAL MEDICINE, 2014, 11 (06): : 1376 - 1391
  • [2] A Review on Phosphodiesterase-5 Inhibitors as a Topical Therapy for Erectile Dysfunction
    Hamzehnejadi, Mohammadsadegh
    Tavakoli, Marziye Ranjbar
    Abiri, Ardavan
    Ghasempour, Ali
    Langarizadeh, Mohammad Amin
    Forootanfar, Hamid
    [J]. SEXUAL MEDICINE REVIEWS, 2022, 10 (03) : 376 - 391
  • [3] COUPLE SATISFACTION TO THE TREATMENT OF ERECTILE DYSFUNCTION WITH PHOSPHODIESTERASE-5 INHIBITORS
    Jiann, Bang Ping
    Huang, S. T.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 105 - 106
  • [4] Phosphodiesterase-5 inhibitors for male erectile dysfunction
    Sui, ZH
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (09) : 1373 - 1388
  • [5] The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction
    Gupta, M
    Kovar, A
    Meibohm, B
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 987 - 1003
  • [6] Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis
    Tsertsvadze, Alexander
    Fink, Howard A.
    Yazdi, Fatemeh
    MacDonald, Roderick
    Bella, Anthony J.
    Ansari, Mohammed T.
    Garritty, Chantelle
    Soares-Weiser, Karla
    Daniel, Raymond
    Sampson, Margaret
    Fox, Steven
    Moher, David
    Wilt, Timothy J.
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 151 (09) : 650 - W218
  • [7] Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction
    Kloner, RA
    [J]. CIRCULATION, 2004, 110 (19) : 3149 - 3155
  • [8] A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil
    Evans, Jeffery D.
    Hill, Stephen R.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 1159 - 1164
  • [9] Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-Analysis Comment
    Seftel, Allen D.
    [J]. JOURNAL OF UROLOGY, 2010, 183 (06): : 2318 - 2319
  • [10] Drug Interactions With Phosphodiesterase-5 Inhibitors Used for the Treatment of Erectile Dysfunction or Pulmonary Hypertension
    Schwartz, Bryan G.
    Kloner, Robert A.
    [J]. CIRCULATION, 2010, 122 (01) : 88 - 95